(S)-1-(4-((5-Methoxypyridin-3-yl)oxy)-5-(1-methylpiperidin-3-yl)pyridin-2-yl)-3-methylurea

ID: ALA4527697

PubChem CID: 155545330

Max Phase: Preclinical

Molecular Formula: C19H25N5O3

Molecular Weight: 371.44

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CNC(=O)Nc1cc(Oc2cncc(OC)c2)c([C@@H]2CCCN(C)C2)cn1

Standard InChI:  InChI=1S/C19H25N5O3/c1-20-19(25)23-18-8-17(27-15-7-14(26-3)9-21-10-15)16(11-22-18)13-5-4-6-24(2)12-13/h7-11,13H,4-6,12H2,1-3H3,(H2,20,22,23,25)/t13-/m1/s1

Standard InChI Key:  KGCLYJCUOWKEBI-CYBMUJFWSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   34.3867   -9.5710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3855  -10.3905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.0936  -10.7995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8032  -10.3901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8004   -9.5674    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0918   -9.1621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6775  -10.7986    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.6768  -11.6158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9687  -12.0223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9677  -12.8387    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6756  -13.2487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3860  -12.8362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.3835  -12.0212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2595  -13.2464    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5116  -10.7976    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.2186  -10.3878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.9270  -10.7953    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   37.2173   -9.5707    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.9244   -9.1610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5523  -12.8369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6796   -9.1627    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6813   -8.3446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9776   -7.9362    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.2676   -8.3415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2658   -9.1597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9741   -9.5725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9805   -7.1191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  2  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 10 14  1  0
  4 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 14 20  1  0
 21 22  1  0
 21 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 21  1  1  6
 23 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4527697

    ---

Associated Targets(Human)

GCK Tchem Hexokinase type IV (3191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 371.44Molecular Weight (Monoisotopic): 371.1957AlogP: 2.84#Rotatable Bonds: 5
Polar Surface Area: 88.61Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.81CX Basic pKa: 8.15CX LogP: 1.17CX LogD: 0.35
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.84Np Likeness Score: -0.91

References

1. Kohn TJ, Du X, Lai S, Xiong Y, Komorowski R, Veniant M, Fu Z, Jiao X, Pattaropong V, Chow D, Cardozo M, Jin L, Conn M, DeWolf WE, Kraser CF, Hinklin RJ, Boys ML, Medina JC, Houze J, Dransfield P, Coward P..  (2016)  5-Alkyl-2-urea-Substituted Pyridines: Identification of Efficacious Glucokinase Activators with Improved Properties.,  (7): [PMID:27437074] [10.1021/acsmedchemlett.6b00145]

Source